Skip to content
10-Q

Quarterly Report

Milestone Pharmaceuticals Inc. MIST

0001558370-25-011141

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 84.99M sh
Capex Q2 2025 · Jun 30, 2025 $17K
Capex Q2 2025 · Jun 30, 2024 $7K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$26.52M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$14.99M
Long Term Debt Q2 2025 · Jun 30, 2025 $55.24M
Long Term Debt Q2 2025 · Dec 31, 2024 $53.35M
Short Term Investments Q2 2025 · Jun 30, 2025 $918K
Short Term Investments Q2 2025 · Dec 31, 2024 $44.38M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $42.5M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $25.31M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$17.75M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$6.12M
Stockholders Equity Q2 2025 · Dec 31, 2024 $13.15M
Stockholders Equity Q2 2025 · Jun 30, 2024 $31.98M
Stockholders Equity Q2 2025 · Mar 31, 2024 $39.92M
Stockholders Equity Q2 2025 · Dec 31, 2023 $16.77M
Current Liabilities Q2 2025 · Jun 30, 2025 $9.28M
Current Liabilities Q2 2025 · Dec 31, 2024 $8.13M
Total Liabilities Q2 2025 · Jun 30, 2025 $65.16M
Total Liabilities Q2 2025 · Dec 31, 2024 $62.35M
Current Assets Q2 2025 · Jun 30, 2025 $46.17M
Current Assets Q2 2025 · Dec 31, 2024 $73.93M
Total Assets Q2 2025 · Jun 30, 2025 $47.42M
Total Assets Q2 2025 · Dec 31, 2024 $75.5M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.20
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.51
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.14
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.34
Eps Basic Q2 2025 · Jun 30, 2025 −$0.20
Eps Basic Q2 2025 · Jun 30, 2025 −$0.51
Eps Basic Q2 2025 · Jun 30, 2024 −$0.14
Eps Basic Q2 2025 · Jun 30, 2024 −$0.34
Sga Expense Q2 2025 · Jun 30, 2025 $3.76M
Sga Expense Q2 2025 · Jun 30, 2025 $8.93M
Sga Expense Q2 2025 · Jun 30, 2024 $5.05M
Sga Expense Q2 2025 · Jun 30, 2024 $9M
Rd Expense Q2 2025 · Jun 30, 2025 $3.67M
Rd Expense Q2 2025 · Jun 30, 2025 $8.65M
Rd Expense Q2 2025 · Jun 30, 2024 $2.82M
Rd Expense Q2 2025 · Jun 30, 2024 $6.45M
Net Income Q2 2025 · Jun 30, 2025 −$12.97M
Net Income Q2 2025 · Jun 30, 2025 −$33.73M
Net Income Q2 2025 · Jun 30, 2024 −$9.36M
Net Income Q2 2025 · Jun 30, 2024 −$19.72M
Operating Income Q2 2025 · Jun 30, 2025 −$12.53M
Operating Income Q2 2025 · Jun 30, 2025 −$33.05M
Operating Income Q2 2025 · Jun 30, 2024 −$9.66M
Operating Income Q2 2025 · Jun 30, 2024 −$20.14M